Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients

Journal of the American Society of Nephrology

Volumn 16, Issue 2, 2005, Pages 539-545

  Bernardini, Judith ^a   Bender, Filitsa ^b   Florio, Tracey ^a   Sloand, James ^c   PalmMontalbano, Linda ^c   Fried, Linda ^a,d   Piraino, Beth ^a,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; PSEUDOMONIC ACID;

ADULT; ARTICLE; BACTERIAL INFECTION; CATHETER INFECTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DEMOGRAPHY; DIALYSIS; DOUBLE BLIND PROCEDURE; GRAM NEGATIVE BACTERIUM; HEALTH CENTER; HUMAN; HYPOTHESIS; INCIDENCE; MAJOR CLINICAL STUDY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; AGED; ANALYSIS OF VARIANCE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; INDWELLING CATHETER; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; OINTMENT; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANALYSIS OF VARIANCE; CATHETERS, INDWELLING; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUPIROCIN; OINTMENTS; PERITONEAL DIALYSIS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 16844363561     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004090773     Document Type: Article

References (39)

1. Gokal R: Peritoneal dialysis in the 21st century: An analysis of current problems and future developments J Am Soc Nephrol 13[Suppl]: S104-S116, 2002
2. Canadian CAPD Clinical Trials Group: Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multicentre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 9: 159-163, 1989
3. Holley JL, Bernardini J, Piraino B: Infecting organisms in continuous ambulatory peritoneal dialysis patients on the Y-set. Am J Kidney Dis 23: 569-573, 1994
4. Abraham G, Savin E, Ayiomamitis A, Izatt S, Vas SI, Mathews RE, Oreopoulos DG: Natural history of exit site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 8: 211-216, 1988
5. Piraino B, Bernardini J, Sorkin M: A five year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 10: 281-286, 1987
6. Flanigan MJ, Hochstetler, Langholdt D, Lim VS: Continuous ambulatory peritoneal dialysis catheter infections: Diagnosis and management. Perit Dial Int 14: 248-254, 1994
7. Gupta B, Bernardini J, Piraino B: Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 28: 415-419, 1996
8. Bayston R, Andrews M, Rigg K, Shelton A: Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 19: 550-555, 1999
9. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC: Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 9: 61-64, 1989
10. Peacock SJ, Howe PA, Day NP, Crok D, Winearls C, Berendt A: Outcome following Staphylococcal peritonitis. Perit Dial Int 20: 215-219, 2000
11. Krothapalli R, Duffy W, Lacke C, Payne W, Patel H, Perez V, Senekjian HO: Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med 142: 1862-1863, 1982
12. Juergensen P, Finkelstein FO, Brennan R, Santacroce S, Ahern M: Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: A six-year study. Am J Kidney Dis 11: 413-417, 1988
13. Bunke M, Brier ME, Golper TA, representing the Academic Committee of Network #9: Pseudomonas peritonitis in peritoneal dialysis patients: The Network #9 Peritonitis Study. Am J Kidney Dis 25: 769-774, 1995
14. Kazmi H, Raffone D, Kliger AS, Finkelstein FO: Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 10: 1498-1501, 1992
15. Lo C, Chu W, Wan K, Ng S, Lee W, Chu M, Cheng S, Lo WK: Pseudomonas exit site infections in CAPD patients: Evolution and outcome of treatment. Perit Dial Int 18: 637-653, 1998
16. Szabo T, Siccion Z, Izatt S, Vas SI, Bargman J, Oreopoulos D: Outcome of Pseudomonas aeruginosa exit-site and tunnel infections: A single center's experience. Adv Perit Dial 19: 209-212, 1999
17. Bernardini J, Piraino B, Sorkin M. Analysis of continuous ambulatory peritoneal dialysis related Pseudomonas aeruginosa infections. Am J Med 83: 829-832, 1987
18. Szeto C, Chow K, Leung C, Wong TY, Wu AK, Wang AY, Lui S, Li PK: Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: A review of 104 cases. Kidney Int 59: 2309-2315, 2001
19. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R: A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 27: 695-700, 1996
20. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG: Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 18: 261-270, 1998
21. Casey M, Taylor J, Clinard P, Graham A, Mauck V, Spainhour L, Brown P, Burkart J: Application of mupirocin cream at the catheter exit sit reduces exit site infections and peritonitis in peritoneal dialysis patients. Perit Dial Int 20: 566-567, 2000
22. Wong S, Chu E, Cheuk A, Tsang WK, Fung SKS, Chan HWH, Tong MKL: Prophylaxis against Gram positive organisms causing exit site infection and peritonitis in continuous ambulatory peritoneal dialysis by applying mupirocin ointment at the catheter exit site. Perit Dial Int 23[Suppl 2]: S153-S158, 2003
23. Piraino B, Bernardini J, Florio T, Fried L: Staphylococcus aureus prophylaxis and trends in Gram negative infections in peritoneal dialysis patients. Perit Dial Int 23: 456-459, 2003
24. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR: Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. J Antimicrob Chemother 27: 495-498, 1985
25. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Vales F: Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing peritoneal dialysis. Am J Kidney Dis 39: 337-341, 2002
26. Annigeri R, Conly J, Vas SI, Dedier H, Prakashan KP, Bargman JM, Jassal V, Oreopoulos D: Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit site infection Perit Dial Int 21: 554-559, 2001
27. Vonesh EF: Modeling peritonitis rates and associated risk factors for individuals on continuous ambulatory peritoneal dialysis. Stat Med 9: 263-271, 1990
28. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Kawaguchi Y, Piraino B, Riella M, Vas S: ISPD guidelines/recommendations. Perit Dial Int 20: 396-411, 2000
29. Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A, Harding G: Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis 36: 1009-1013, 2000
30. Cho P, Nemati E, Banerjee A, Preston E, Levy J, Brown E: Peritoneal dialysis catheter removal for acute peritonitis: A retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis 43: 103-111, 2004
31. Szeto C, Chow K, Wong T, Leung CB, Wang AY, Lui SF, Li PK: Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol 13: 1040-1045, 2002
32. Fried LF, Bernardini J, Johnston JR, Piraino B: Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 7: 2176-2182, 1996
33. Prasad N, Gupta A, Sharma R, Prasad K, Gulati S, Sharma A: Outcome of Gram positive and Gram negative peritonitis in patients on continuous ambulatory peritoneal dialysis: A single center experience. Perit Dial Int 23[Suppl 2]: S144-S147, 2003
34. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F: Differing outcomes of Gram positive and Gram negative peritonitis. Am J Kidney Dis 32: 623-628, 1998
35. Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: Gram negatives versus Gram positives in the Network 9 Peritonitis. Kidney Int 52: 524-529, 1997
36. Cox CE. Gentamicin. Med Clin North Am 54: 1310, 1970
37. Shemin D, Maaz D, St. Pierre D, Kahn SI, Chazan JA: Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients. Am J Kidney Dis 34: 14-20, 1999
38. Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, Choi KY, Ha SK, Lee HY, Han DS: Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 19: 138-142, 1999
39. Singhal MK, Bhaskaran S, Vidgen E, Barman JM, Vas SI, Oreopoulos DG: Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 20: 429-438, 2000